Sr. Clinical Trial Manager

Scorpion Therapeutics; United States; Remote; USD 150,000 - 195,000; Full time

Job summary

Scorpion Therapeutics seeks a Senior Clinical Trial Manager to oversee Phase I–III radiopharmaceutical oncology trials. You will plan, execute, and close studies while coordinating CROs and internal teams to ensure high-quality data and compliance.

The role requires 5–7 years in clinical operations, a BA/BS in a scientific field, and strong vendor oversight. Remote work is available in the United States with up to 20% travel.

Qualifications

• 5-7 years of experience in clinical operations within biotech, pharma, or CROs.
• BA/BS in a scientific or healthcare field; expertise in clinical trial management and regulatory compliance.

Responsibilities

• Plan, execute, and close trials across Phase I–III with radiopharmaceuticals.
• Manage CROs and vendors; monitor timelines, quality, and budgets.
• Ensure GCP/ICH/FDA compliance and lead cross-functional teams.

Skills

Clinical operations

CRO/vendor management

Regulatory compliance

Budget management

Cross-functional leadership

Education

BA/BS in a scientific or healthcare field

Job description

Role

Senior Clinical Trial Manager overseeing Phase I–III clinical studies for radiopharmaceutical therapies targeting solid tumors in oncology.

Responsibilities

Planning, executing, and closing trials, managing CROs and vendors, ensuring compliance with GCP/ICH/FDA regulations, monitoring progress, and mitigating risks. The role requires leading cross-functional teams, managing budgets, and participating in site feasibility and startup activities.

Qualifications

5-7 years of experience in clinical operations within biotech, pharma, or CROs, with a BA/BS in a scientific or healthcare field; expertise in clinical trial management, vendor oversight, and regulatory compliance.

High-Value

Oncology, radiopharmaceutical modality, Phase I–III, regulatory compliance, CRO/vendor management, and cross-functional collaboration.

Work setup

Remote in the US, with up to 20% travel.